{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:11:23Z","timestamp":1789506683183,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["INV-071320"],"award-info":[{"award-number":["INV-071320"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128908","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:48:40Z","timestamp":1784130520000},"page":"128908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Estimating the impact of Shigella vaccines on growth outcomes and implications for clinical trial design"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6562-607X","authenticated-orcid":false,"given":"Allison","family":"Codi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4942-3747","authenticated-orcid":false,"given":"Elizabeth","family":"Rogawski McQuade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Benkeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2026.128908_b1","doi-asserted-by":"crossref","first-page":"e1309","DOI":"10.1016\/S2214-109X(18)30349-8","article-title":"Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study","volume":"6","author":"Platts-Mills","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"10051","key":"10.1016\/j.vaccine.2026.128908_b2","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(16)31529-X","article-title":"Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128908_b3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008536","article-title":"Epidemiology of Shigella infections and diarrhea in the first two years of life using culture-independent diagnostics in 8 low-resource settings","volume":"14","author":"Rogawski McQuade","year":"2020","journal-title":"PLOS Neglected Trop Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128908_b4","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S1473-3099(18)30475-4","article-title":"Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990\u20132016","volume":"18","author":"Khalil","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"Supplement_7","key":"10.1016\/j.vaccine.2026.128908_b5","doi-asserted-by":"crossref","first-page":"S848","DOI":"10.1093\/infdis\/jiab434","article-title":"Pathogens Associated With Linear Growth Faltering in Children With Diarrhea and Impact of Antibiotic Treatment: The Global Enteric Multicenter Study","volume":"224","author":"Nasrin","year":"2021","journal-title":"J Infect Dis"},{"issue":"9609","key":"10.1016\/j.vaccine.2026.128908_b6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0140-6736(07)61692-4","article-title":"Maternal and child undernutrition: consequences for adult health and human capital","volume":"371","author":"Victora","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128908_b7","series-title":"The height premium: a literature review and meta-analysis","author":"Puett","year":"2023"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128908_b8","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/S2214-109X(22)00448-X","article-title":"Early-life stature, preschool cognitive development, schooling attainment, and cognitive functioning in adulthood: a prospective study in four birth cohorts","volume":"11","author":"Stein","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128908_b9","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3390\/antibiotics11111653","article-title":"Prevalence of Multidrug-Resistant and Extended-Spectrum Beta-Lactamase-Producing Shigella Species in Asia: A Systematic Review and Meta-Analysis","volume":"11","author":"Salleh","year":"2022","journal-title":"Antibiotics"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128908_b10","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3390\/vaccines10091376","article-title":"The Shigella Vaccines Pipeline","volume":"10","author":"MacLennan","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.128908_b11","series-title":"WHO Preferred Product Characteristics for Vaccines Against Shigella","year":"2021"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128908_b12","doi-asserted-by":"crossref","first-page":"e892","DOI":"10.1016\/S2214-109X(23)00050-5","article-title":"Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling study","volume":"11","author":"Puett","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128908_b13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2471\/BLT.23.290163","article-title":"Reassessing potential economic value and health impact of effective Shigella vaccines","volume":"102","author":"Hausdorff","year":"2024","journal-title":"Bull World Health Organ"},{"issue":"473","key":"10.1016\/j.vaccine.2026.128908_b14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1198\/016214505000000970","article-title":"Causal Vaccine Effects on Binary Postinfection Outcomes","volume":"101","author":"Hudgens","year":"2006","journal-title":"J Amer Statist Assoc"},{"key":"10.1016\/j.vaccine.2026.128908_b15","series-title":"Causal vaccine effects on post-infection outcomes in the naturally infected","author":"Codi","year":"2026"},{"key":"10.1016\/j.vaccine.2026.128908_b16","series-title":"Effects of shigella diarrhea with and without antibiotic treatment on linear growth: an individual patient data meta-analysis of five multisite studies among children in low-resource settings","author":"Rogawski McQuade","year":"2026"},{"issue":"9888","key":"10.1016\/j.vaccine.2026.128908_b17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128908_b18","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/sim.4780091208","article-title":"Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk","volume":"9","author":"Farrington","year":"1990","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128908_b19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/vaccines10040489","article-title":"Pivotal Shigella Vaccine Efficacy Trials\u2014Study Design Considerations from a Shigella Vaccine Trial Design Working Group","volume":"10","author":"Pavlinac","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.128908_b20","author":"Yousafzai","year":"2026","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128908_b21","doi-asserted-by":"crossref","first-page":"e00073","DOI":"10.1128\/msphere.00073-23","article-title":"Development of the Shigella flexneri 2a, 3a, 6, and s. sonnei artificial Invaplex (InvaplexAR) vaccines","volume":"8","author":"Turbyfill","year":"2023","journal-title":"MSphere"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128908_b22","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/vaccines12101091","article-title":"Evaluation of a Quadrivalent Shigella flexneri Serotype 2a, 3a, 6, and Shigella sonnei O-Specific Polysaccharide and IpaB MAPS Vaccine","volume":"12","author":"Boerth","year":"2024","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128908_b23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.101064","article-title":"Epidemiology of Shigella species and serotypes in children: a retrospective substudy of the MAL-ED observational birth cohort study","volume":"6","author":"Rogawski McQuade","year":"2025","journal-title":"Lancet Microbe"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128908_b24","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1093\/cid\/ciaa1545","volume":"73","author":"Pavlinac","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128908_b25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103310","article-title":"Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection","volume":"66","author":"Talaat","year":"2021","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128908_b26","doi-asserted-by":"crossref","first-page":"e1319","DOI":"10.1016\/S2214-109X(18)30351-6","article-title":"Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings: longitudinal analysis of results from the MAL-ED cohort study","volume":"6","author":"Rogawski","year":"2018","journal-title":"Lancet Glob Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:38:06Z","timestamp":1789504686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26007176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":26,"alternative-id":["S0264410X26007176"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128908","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating the impact of Shigella vaccines on growth outcomes and implications for clinical trial design","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128908"}}